- About SEAS
- Faculty & Research
- News & Events
- Offices & Services
- Make a Gift
Gold nanoparticles promise potential improvements in cancer treatment, drug delivery, and gene therapy — with one, major problem.
In order for the particles to destroy a tumor or create holes in cell membranes to deliver DNA, they need to be irradiated with a high-powered laser. This process excites the nanoparticle’s electrons and generates localized surface plasmons, which increases the electric field close to the surface of the particle. These super-excited nanoparticles can do all kinds of things, such as increase the temperature of water and destroy cells.
But the irradiation process can also damage the nanoparticle, splintering off tiny, but potentially toxic, pieces of gold. Even the smallest spec of free-floating gold can wreak havoc in cells and cause genetic mutations.
To overcome this problem, Harvard researchers are developing the next generation of gold microstructures, replacing the free-floating particle with pyramid-shaped gold structures anchored to a flat surface. These microstructures are more stable than traditional nanoparticles and focus laser energy into intense electromagnetic near fields.
This new platform was developed in the lab of Eric Mazur, the Balkanski Professor of Physics and Applied Physics and Area Dean for Applied Physics at Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS), and is described in a paper published in the journal Nano Letters.
“This system will allow us to control the transfection process in a reproducible manner,” said Mazur.
“After we get a better sense of what this system is capable of, we hope to work closely with biologists to develop specific applications both in genetic treatment and basic biomedical research,” said Nabiha Saklayen, coauthor of the paper and PhD candidate in the Mazur lab.
This research is part of an international collaboration between SEAS, the University of Geneva, and UCLA. The paper was coauthored by Marinus Huber, Jun Chen, Eric Diebold, Luigi Bonacina and Jean-Paul Wolf.
This research was supported by the National Science Foundation (PHY-1219334 and PHY-1205465), the Swiss National Foundation, the Ernest Boninchi Foundation, the American Association for University Women, and the Howard Hughes Medical Institute.